Ownership and insider activity for Senseonics Holdings, Inc. (SENS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
Price
| Price | $9.06 |
| Market Cap | $379M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13.0M | $16.1M | $136.8M | $95.9M | $18.0M | $33.5M | $35.8M | $75.7M | $74.6M | $40.5M |
| Short-term Investments | $7.3M | $20.3M | 0 | 0 | 0 | $96.4M | $108.2M | $33.7M | 0 | $53.8M |
| Receivables | $251000 | $3.4M | $7.1M | $10.5M | $3.0M | $2.4M | $2.8M | $6.6M | $8.1M | $12.4M |
| Inventory | $477000 | $3.0M | $10.2M | $16.9M | $5.3M | $6.3M | $7.3M | $8.8M | $4.4M | $6.7M |
| Total Current Assets | $21.4M | $44.9M | $158.1M | $127.8M | $30.2M | $144.4M | $161.2M | $130.0M | $91.4M | $117.5M |
| Property, Plant & Equipment | $735000 | $853000 | $1.8M | $2.0M | $1.6M | $1.3M | $1.1M | $1.2M | $3.6M | $4.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $481920 | $800000 |
| Total Assets | $22.3M | $45.9M | $160.0M | $132.8M | $35.9M | $198.9M | $177.7M | $138.2M | $100.4M | $126.3M |
| Accounts Payable | $3.1M | $7.7M | $4.4M | $4.3M | $1.8M | $1.2M | $419000 | $4.6M | $3.2M | $4.1M |
| Short-term Debt | $3.9M | $10.0M | $10.0M | $103.8M | $3.2M | $2.9M | $15.6M | 0 | $20.1M | $496000 |
| Total Current Liabilities | $11.6M | $23.1M | $28.9M | $126.7M | $16.6M | $18.4M | $31.5M | $17.3M | $38.8M | $24.3M |
| Long-term Debt | $15.2M | $14.4M | $41.0M | $11.8M | $57.2M | $59.8M | $56.4M | $41.2M | $34.7M | $35.6M |
| Total Liabilities | $27.1M | $38.7M | $88.7M | $141.4M | $180.0M | $384.5M | $180.2M | $102.4M | $117.0M | $65.2M |
| Retained Earnings | -$204.7M | -$263.8M | -$357.8M | -$473.3M | -$648.5M | -$951.0M | -$808.9M | -$869.3M | -$947.9M | -$1.02B |
| Total Equity | -$4.9M | $7.3M | $71.3M | -$8.6M | -$144.1M | -$185.5M | -$2.6M | $35.8M | -$16.6M | $61.0M |
| Total Debt | $19.2M | $24.5M | $51.0M | $118.6M | $62.7M | $64.2M | $75.4M | $47.8M | $61.1M | $41.4M |
| Net Debt | -$1.1M | -$12.0M | -$85.8M | $22.6M | $44.7M | -$65.7M | -$68.6M | -$61.7M | -$13.5M | -$52.7M |
| Working Capital | $9.8M | $21.8M | $129.2M | $1.1M | $13.6M | $126.0M | $129.7M | $112.8M | $52.6M | $93.2M |
Financial Health
| Debt / Equity | 0.68 |
| Current Ratio | 6.74 |
Profitability
| Return on Equity | -113.21% |
| Return on Invested Capital | -66.72% |
| Return on Assets | -54.73% |
| Gross Margin | 54.87% |
| Operating Margin | -223.22% |
| Net Margin | -225.34% |
Related companies: ACRS · CAPR · CERS · CVRX · MASS · NNOX · NPCE
Explore sector: Healthcare · Medical - Devices
More sections of SENS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks